Search results
Roche's (RHHBY) Combo Therapy Misses Lung Cancer Study Goals
Zacks via Yahoo News· 7 days agoRoche (RHHBY) announces that its mid to late-stage lung cancer study evaluating the tiragolumab...
The Zacks Analyst Blog Highlights Eli Lilly, Sanofi Merck, AstraZeneca's and Roche
Zacks via Yahoo News· 3 days agoRoche Halts NSCLC Study on Tiragolumab Combo: Roche’s phase II/III lung cancer study on tiragolumab...
If You Invested $1000 in Eli Lilly a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo News· 3 days ago(a neuroscience drug discovery company focused on sleep disorders), CoLucid Pharmaceuticals (which...